Show simple item record

dc.contributor.authorBeattiea, Tara
dc.contributor.authorKaulb, Rupert
dc.contributor.authorRostrona, Tim
dc.contributor.authorDonga, Tao
dc.contributor.authorEasterbrook, Philippa
dc.contributor.authorJaoko Walter G.
dc.contributor.authorKimani, Joshua
dc.contributor.authorPlummer, Francis
dc.contributor.authorMcMichael, Andrew
dc.contributor.authorRowland-Jones, Sarah
dc.date.accessioned2013-06-03T11:37:21Z
dc.date.available2013-06-03T11:37:21Z
dc.date.issued2004
dc.identifier.citationResearch Letters AIDS 2004, 18:1595–1606en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/15238779
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/28714
dc.description.abstractThe IFN-ª enzyme-linked immunospot (ELISpot) assay is often used to map HIV-specific CD8 T-cell responses. We compared overlapping 15-mer pools with optimized CD8 epitopes to screen ELISpot responses in HIV-infected individuals. The 15-mer pools detected responses to previously undefined epitopes, but often missed low-level responses to predefined epitopes, particularly when the epitope was central in the 15-mer, rather than at the N-terminus or Cterminus. These factors should be considered in the monitoring of HIV vaccine trials.en
dc.language.isoenen
dc.publisherUnivesity of Nairobien
dc.titleScreening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopesen
dc.typeArticleen
local.publisherDepartment of Medicineen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record